Side effects of gemcitabine plus cisplation therapy and navelbine plus cisplation therapy for non-small cell lung cancer
LIU Shu-mei
YANG Hai-tao
JI Shu-yu
GUO Shi-dun
Abstract：Objective To evaluate side effects of gemcitabine plus cisplation (GP Programme) therapy and navelbine plus cisplation (NP programme) therapy for non-small cell lung cancer (NSCLC). Methods Eight-five advanced non-small cell lung cancer patients were divided into 2 groups: 42 with GP and 43 with NP. Results The response rates of GP and NP group were 40.5% and 39.5% respectively. There was no significant difference in response rate between the two groups (P>0.05). The major adverse reactions were myelosuppression. Thrombocytopenia in GP Group was higher than NP group, leukopenia in NP Group was higher than GP group. Conclusion Both GP and NP regimens are effective for advanced NSCLC. The side effects of the two regimens are different but all adverse reactions are tolerable.
Keywords：Non-small cell lung cancerGemcitabineNavelbineCisplation
Publication Date：2009-01-01
Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)
Pages：2( 103-104 )